Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 38, Issue 9

Issues

Idiosyncratic Reactions to Drugs: Can Medicine Response Profiles Provide a Dynamic Drug Surveillance System?

Allen D. Roses
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.117

Abstract

Over the next few years it will be possible to use advances in single nucleotide polymorphism map technology to correlate information from patients' DNA with their response to medicines. This provides significant opportunities to enhance current drug surveillance systems by collecting data that would enable rare serious adverse events to be predicted in subsequent patients before the medicine is prescribed. Reasonable discussion regarding perceived or real barriers to this surveillance concept is required to realize the significant patient benefits which will accrue from this system.

About the article

Published Online: 2005-06-01

Published in Print: 2000-09-18


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 38, Issue 9, Pages 815–818, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.117.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Allen D Roses
The Pharmacogenomics Journal, 2002, Volume 2, Number 5, Page 277
[2]
Orest Hurko
European Neuropsychopharmacology, 2001, Volume 11, Number 6, Page 491
[3]
Wendell W. Weber
Paediatric Drugs, 2001, Volume 3, Number 12, Page 863
[4]
Susan T. Hall, Neil Abbott, Ginny Schmith, and Celia Brazell
Drug Development Research, 2004, Volume 62, Number 2, Page 102

Comments (0)

Please log in or register to comment.
Log in